[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Reinfection with South African variant", "description": "Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report \n\nhttps://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab129/6132402\n\nJournal of Clinical Infectious Diseases, 10 February 2021\n\nReinfections\n\nRare albeit probably underestimated\n\nConfirmed cases worldwide, 31 \n\nIn most cases less severe than the initial infection\n\nA case of severe SARS-CoV-2 reinfection with South African variant 501Y.V2\n\nSeptember, mild COVID-19, no genomic sequencing\n\n58-year old immunocompetent male\n\nHistory of asthma\n\nDecember, tested negative twice\n\nJanuary 2021, 129 days later, recurrent dyspnea and fever\n\nK417N, E484K and N501Y in RBD\n\n5 others in spike protein\n\nSeven days later, severe acute respiratory distress syndrome\n\nRequiring intubation and mechanical ventilation\n\nSA variant not previously associated with more severe disease\n\nDexamethasone and tocilizumab\n\nAntibody testing was positive for IgG against SARS-CoV-2\n\n\nPeru\n\nhttps://www.aljazeera.com/news/2021/2/15/peru-foreign-minister-resigns-over-covid-vaccine-scandal\n\nForeign minister, vaccinated last month, resigned\n\nHealth Minister, resigned\n\nEarly vaccination of senior officials\n\nHospitals overwhelmed\n\nHealth workers rolling, from February 8, 300,000 doses\n\n\n\nAustralia\n\nVictoria\n\nUK variant, 16 cases\n\nCluster, workers at a quarantine hotel at Melbourne airport\n\nFive day lockdown\n\nTwo new cases of locally transmitted infections, 3 year old\n\nNew Zealand\n\nThree unexplained cases\n\nOne family\n\nAirline catering laundry worker\n\nThree-day lockdown in Auckland\n\nJapan\n\nApproves BioNTech-Pfizer vaccine\n\nStarting next week\n\nSmall sample size of the extra trial\n\nGermany\n\nhttps://www.dw.com/en/germany-angela-merkel-vows-to-improve-coronavirus-vaccine-rollout-but-warns-of-mutations/a-56556191\n\ndisappointment\n\nat full capacity, end of March / April\n\nsmart to avoid a third wave, March 7th \n\nUK, Ten day hotel quarantine starts today\n\nhttps://www.bbc.co.uk/news/uk-56064759\n\nEngland, red list of 33 countries\n\nScotland, all international arrivals\n\n\u00a31, 750\n\n\u00a3650 for additional adult\n\nPriority groups\n\nVaccinations\n\nFirst dose, 15,062,189\n\nSecond dose, 537,715\n\nhttps://coronavirus.data.gov.uk/details/cases\n\n \n\nhttps://www.gov.uk/government/publications/covid-19-vaccination-care-home-and-healthcare-settings-posters/covid-19-vaccination-first-phase-priority-groups\n\nStarting group 5\n\nAll those 65 years of age and over\n\nNext, group 6\n\nAdults aged 16 to 65 years in an at-risk group\n\n\n\n\n\n\n\n\nExcess mortality reveals Covid's true toll in Russia\n\n \n\nhttps://rss.onlinelibrary.wiley.com/doi/10.1111/1740-9713.01486\n\n1 January 2021, Deaths\n\nRussia 57,600 deaths (0.04% of population)\n\nPeru (0.12%)\n\nSpain (0.11%)\n\nUK (0.11%)\n\nUSA (0.11%)\n\n\nExcess mortality in Russia from April to November\n\nExcess deaths, 264,100 \n\nEstimate of excess mortality is 6.5 times than the 40,500 deaths reported\n\nApril to November, 0.18% of the country's population\n\n\nRatio of 6.5, largest ratio across all countries\n\nDaily reported death count for Russia, one of the least reliable indicators of epidemiological situation across all countries\n\nBy comparison\n\nUS, x 1.3\n\nMexico, x 2.5\n\nItaly, x 1.7\n\nUK, x 1.5\n\nSpain, x 1.4\n\nIran, x 2.4\n\nGermany, x 1.2\n\nPoland, x 2.9\n\nSouth Africa, x 2.1\n\nRussia, 14th February 2021\n\nPopulation, 144 million\n\nOfficial death figures, 78,825 (JH)\n\nX 6.5 = 512,362\n\n0.35% of population", "link": "https://www.youtube.com/watch?v=5Fpc5QXfAVQ", "date_published": "2021-02-15 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Transatlantic update and personal experience", "description": "United States\n\nCases, + 102,004 = 27,229.862\n\nDearth, +3,589 = 474,423 (0.14% of population)\n\nHospitalizations, 69,283 (14,369, 4,643)\n\nVaccine doses since 14th December, 50, 641,884\n\nFirst dose, 37,056,122\n\nBooster doses, 13,082,172 (4.08%)\n\nUS COVID-19 Cases Caused by Variants\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html\n\nUS B.1.1.7 dashboard\n\nhttps://www.helix.com/pages/helix-covid-19-surveillance-dashboard\n\nFlorida\nCalifornia\nGeorgia\nTexas\n\nCDC data\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nPast 7 days\n\nhttps://www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=sf_coronavirus\n\nNew daily reported cases, down 22.1%\n\nNew daily reported deaths, down 5.8%\n\nCoViD related hospitalizations, down 17.8%\n\nTest positivity rate, 5.8%\n \nhttps://covidtracking.com/data\n\nUnited kingdom\n\nUK data\n\nCases, + 13,308 = 4,027,106\n\nDeaths, + 621 = 116,908 (0.18% of population)\n\nVaccinations\n\nFirst dose, 14,556,827\n\nSecond dose, 534,869\n\nhttps://coronavirus.data.gov.uk/details/cases\n\nTracker app data\n\nhttps://covid.joinzoe.com/data#levels-over-time\n\nhttps://twitter.com/DavidDavisMP\n\nOxford University extends COVID-19 vaccine study to children\n\nhttps://www.ovg.ox.ac.uk/news/oxford-university-extends-covid-19-vaccine-study-to-children\n\n 13th February\n\nLondon, Southampton and Bristol\n\nSafety and immune responses in children and young adults\n\nAges, 6 to 17 years\n\nSingle-blind, randomised phase II trial\n\nN =  300 volunteers\n\nVaccine group, n = 240\n\nControl group, n = 60, meningitis vaccine\n\nSafe and gives a sore arm\n\nAndrew Pollard\n\nProfessor of Paediatric Infection and Immunity, and Chief Investigator on the Oxford vaccine trial\n\nWhile most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, \n\nit is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination. \n\nThese new trials will extend our understanding of control of SARS-CoV2 to younger age groups\n\nStarting trials for younger children this spring\n\nPfizer\n\nModerna\n\nJanssen", "link": "https://www.youtube.com/watch?v=_Y2VaJhjhFc", "date_published": "2021-02-14 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]